The News Review:

- Clinical Research: Men’s experiences of partners’ postnatal…
- The Food & Drug Letter
- FDA Clears Advanced Test For Monitoring Metastatic Colorectal Cancer

Clinical Research: Men’s experiences of partners’ postnatal…
Nursing Times – Nov 23, 2007
Abstract Muchena G. (2007) Men’s experiences of partners’ postnatal mental illness. Nursing Times; 103: 48. This study explored men’s reactions to fatherhood and their knowledge and atti.

The Food & Drug Letter
FDA news – FDA news (subscription) – Nov 23, 2007
The summit was held in St. in ctober and was sponsored by FDAnews and RxTrials. Participants agreed that sites face many of the same challenges despite their diversity in size and business structure… in ctober and was sponsored by FDAnews and RxTrials. Participants agreed that sites face many of the same challenges despite their diversity in size and business structure. They are underrepresented in a clinical research enterprise dominated by sponsors and CRs and they face chronic cash flow and contractual problems compared with these often more powerful entities. Nevertheless sites can do research successfully and make money if they understand they are running businesses and organize themselves accordingly. Patient recruitment efforts must be subjected to rigorous professional advertising techniques and systematic budgeting; the days of fliers and brochures are largely over.

FDA Clears Advanced Test For Monitoring Metastatic Colorectal Cancer
Medical News Today – Medical News Today (press release) – Nov 23, 2007
Data showed that patients with less than three CTCs at baseline had significantly better survival rates versus patients with more than three CTCs an overall finding consistent with metastatic breast cancer patients. Data also showed that CTCs are a strong independent predictor of progression-free survival and overall survival and that the combination of CTC analysis and radiological assessment may provide the most accurate assessment of prognosis. “Clinical research validates the significance of circulating cancer tumor cells” said Robert McCormack Ph. Vice President of Medical and Scientific Affairs Veridex. “Elevated CTCs in the blood stream are associated with lower survival rates. We believe based on the clinical research that identifying CTCs as soon as possible can lead to improved patient outcomes… Vice President of Medical and Scientific Affairs Veridex. “Elevated CTCs in the blood stream are associated with lower survival rates. We believe based on the clinical research that identifying CTCs as soon as possible can lead to improved patient outcomes. The CellSearch™ test works by using antibodies that are joined to microscopic iron particles called ferrofluid. Powerful magnets then “pull” the CTCs out of the blood sample. They are then stained with additional bio-molecules and chemicals so that they can be positively identified as CTCs.